CYRX
Cryoport, Inc.
NASDAQ · Industrials · Integrated Freight & Logistics · US
$15.91
+0.32%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−219.7x
Market Cap
$805.83M
MomentumView details →
1D Return
+0.32%
YTD Return
+65.75%
RSI (14)
51.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−219.7x
Market Cap
$805.83M
RSI (14)
51.1
MomentumView details →
1D Return
+0.32%
YTD Return
+65.75%
SummaryUpdated Jun 1, 2026
Cryoport, Inc. (NASDAQ:CYRX) is a Tennessee-based life sciences services company founded in 1999 that specializes in temperature-controlled logistics solutions for the biotechnology and pharmaceutical industries. The company went public in 2005 and has evolved from a niche cryogenic shipping provider into a comprehensive logistics platform serving the rapidly growing cell and gene therapy market. Today, Cryoport operates globally across the Americas, Europe, the Middle East, Africa, and Asia Pacific, supporting over 675 clinical trials and 14 commercial therapies through its integrated suite of logistics services and cryogenic systems.
Similar companies
CN Logistics International Holdings Limited02130.HKFAR International Holdings Group Company Limited02516.HKGuangdong Yueyun Transportation Company Limited03399.HKForward Air CorporationFWRDInfinity Logistics and Transport Ventures Limited01442.HKYTO International Express and Supply Chain Technology Limited06123.HKFind similar companies →
Latest newsMore news →
Cryoport reported its second quarter 2026 financial results, with revenue growing 8% year-over-year to $49.0 million and Life Sciences Services revenue up 15%, BioStorage/BioServices revenue up 25%, supporting 779 global clinical trials and 22 commercially approved cell and gene therapies as of June 30, 2026.29d agoCryoport's IntegriCell cryopreservation services were selected by Verismo Therapeutics to support its clinical KIR-CAR T cell therapy programs.71d ago